Harvey R. Samowitz, M.D., F.A.C.S.
American Board of Urology Certification, Recertified October 2012
Subspecialty Certification in Female Pelvic Medicine and Reconstructive Surgery, certified June 2013
Fellow of American College of Surgeons, Member since 1995
National Board of Medical Examiners
California Medical License G058847
Florida Medical License ME62933
Andrew Warde High School, Fairfield, Connecticut; Valedictorian, 1976
Duke University, Magna cum Laude, B.S., Majors in Zoology and Philosophy, 1980
Chicago Medical School/University of Health Sciences, 1980-1982
University of Connecticut School of Medicine, M.D., 1984
Michael Reese Hospital/University of Chicago Affiliates, Surgery Resident, 1984-1986
Stanford University, Pathology Resident, 1986-1987
University of Medicine and Dentistry of New Jersey, Newark, NJ, Urology Resident, 1987-1991
Northern California Incontinence Clinic, San Pablo, CA, Clinical Fellowship in Female Urology, Incontinence and Voiding Dysfunction, 1991-1992
American Urological Association (AUA)
American College of Surgeons (ACS)
Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU)
Society of Laparoendoscopic Surgeons (SLS)
Robotic And Micro-Surgical Endoscopic Society (RAMSES)
American Medical Association (AMA)
American Mensa Society
Dade County Medical Association
Broward County Medical Association
Greater Miami Urological Society (GMUS)
Phi Delta Epsilon Medical Fraternity, Beta Tau Chapter
AWARDS, OFFICES AND HONORS
National Psoriasis Foundation, Addie L. Brewood Predoctoral Fellowship, 1979
Program Director of the Fourth National Undergraduate Conference on Bioethics, 1979
Magna cum Laude, Duke University
Medical School Yearbook Editor, 1981
Clinical Assistant Professor, University of California at Davis Medical School, 1991-1995
American College of Surgeons Fellow, 1996
Greater Miami Urological Society, Secretary, 1996-1997
Greater Miami Urological Society, President, 1997 – present
Clinical Assistant Professor, Nova Southeastern University Medical School, 2004 – 2011
Clinical Associate Professor, Nova Southeastern University Medical School, 2011 – present
Patients’ Choice Most Compassionate Doctor Award 2008, 2009, 2010, 2011, 2013
SPECIAL TRAINING, SKILLS AND CERTIFICATION
Mini-Fellowship in Minimally Invasive Treatment of Renal Tumors, University of California, Irvine
Laparoscopic and Robotic Laparoscopic Urologic Surgery
Cryotherapy and Radiofrequency Ablation of Urologic Tumors
Urodynamics, Voiding Dysfunction, and Female Urology
Interstitial Cystitis and Pelvic Pain Syndrome
Pelvic Reconstructive Surgery
Pelvic Organ Prolapse
Female and Male Urinary Incontinence
Transurethral Bulking Agents for Incontinence
Botulinum Toxin Bladder Injection
Sacral Neuromodulation for Urinary Control (Interstim)
Percutaneous Extraction of Testicular Sperm (PETS, TESE)
Microsurgical Vasectomy Reversal
No-Scalpel, No Needle Vasectomy
Radiation Seed Brachytherapy for Prostate Cancer
Laser Photoselective Vaporization of the Prostate (PVP, Greenlight, Evolve)
Transurethral Microwave Thermotherapy (TUMT)
Transurethral Needle Ablation of Prostate(TUNA)
Florida Workers Compensation Physicians Certification
NIH Clinical Research Investigator Certification
The Pelvic and Voiding Disorders Clinic, Founder and Director, Aventura and Pembroke Pines, Florida; January 2005 to present
21st Century Oncology, Urology Division, Group Practice, Dade and Broward Counties, Florida; November 2007 to present
Uro-Medix, Inc., Medical Co-Director, Group Urologic Practice, Dade and Broward Counties, Florida; January 1999 to October 2007
Uro-Care, P.A.; Group Urologic Practice; Dade and Broward Counties; June 1996 to December 1998
South Florida Medical Research, Clinical Research Associate, Aventura, Florida; June 1996 to present
MedClinic, Inc.; Multi-Specialty Group Practice, Sacramento, California; August 1994 to March 1996
Pacific Urologic Associates, Private Practice; Davis, California; August 1992 to July 1994
Aventura Hospital and Medical Center, Aventura
Memorial Hospital West, Pembroke Pines
Jackson North Medical Center, North Miami Beach
North Miami Beach Surgical Center, North Miami Beach
Singer, KH, Sawka, NJ, Samowitz, HR., and Lazarus, GS; Proteinase Activation: A Mechanism for Cellular Dyshesion in Pemphigus
Journal of Investigative Dermatology, 74:363, 1980.
Hanna, MK and Samowitz, HR; The Rationale for Partial Nephrectomy in Selected Cases of Unilateral Wilms Tumor
Dialogues in Pediatric Urology, 14:3 November 1991.
Dmochowski R, Chapple C, Nitti VW, et al.: Efficacy and Safety of Onabotulinumtoxin A for Idiopathic Overactive Bladder:
A Double-Blind, Placebo Controlled, Randomized, Dose Ranging Trial Journal of Urology, 184:2416–2422, 2010.
SOUTH FLORIDA MEDICAL RESEARCH EXPERIENCE
Available on request, 1996 to present
THE PELVIC AND VOIDING DISORDERS CLINIC RESEARCH EXPERIENCE
“Interstitial Cystitis Urine Markers,” Biotheme. Principal Investigator. February to June 2005.
“Use of RT-PCR for the Detection of Upregulated Genes to Predict Presence of Prostate Cancer in Patients About to Undergo a Prostate Biopsy,”
Protocol IMMC-35A: Principal Investigator. July 2005 to December 2006.
“Clinical Investigation of the ProACT™ Adjustable Continence Therapy for Treatment of Post-Prostatectomy Stress Urinary Incontinence, ”
Protocol Number: UM02: Principal Investigator. May 2005 to May 2007.
“A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Dose Response Study of the Safety and Efficacy of a Single Treatment of BOTOX™
(Botulinum Toxin Type A) Purified Neurotoxin Complex in Patients with Idiopathic Overactive Bladder with Urinary Urge Incontinence”
Protocol Number 191622-077: Principal Investigator, August 2006 to October 2008.
“A Multicenter, Randomized, Placebo-Controlled, Double-Blind Phase 3 Trial of Single-Dose Intravesical EOquin as a Surgical Adjuvant Instilled in
the Early Postoperative Period in Patients Undergoing Transurethral Resection for Noninvasive Bladder Cancer,”
Protocol SPI-612: Principal Investigator, May 2009 to present.
“A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of a Single Treatment of BOTOX®
(Botulinum Toxin Type A) Purified Neurotoxin Complex Followed by a Treatment with BOTOX®
as Applicable in Patients with Idiopathic Overactive Bladder with Urinary Incontinence,”
Protocol 191622-520: Principal Investigator, November 2009 to August 2011.
“ Pilot, Multicenter, Double-blind, Placebo-controlled, Dose-escalation Study of the Safety and Efficacy of AGN-214868 in Patients with
Idiopathic Overactive Bladder and Urinary Incontinence,”
Protocol 214868-004: Sub-Investigator, July 2011 to present.
“A Multicenter, Long-term Follow-up Study of the Safety and Efficacy of BOTOX® (Botulinum Toxin Type A)
Purified Neurotoxin Complex in Patients with Idiopathic Overactive Bladder with Urinary Incontinence,”
Protocol 191622-096: Principal Investigator, July 2011 to present.
PRESENTATIONS AND ABSTRACTS
“Partial Nephrectomy in Wilms Tumor.” Samowitz, HR. Ferdinand C. Valentine Urology Prize Essay Meeting. New York, New York; April 1990.
“Partial Nephrectomy for Unilateral Wilms Tumor.” Samowitz, HR and Hanna MK.
American Academy of Pediatrics Annual Meeting, Section on Urology. Boston, Massachusetts; October 1990.
“Management of Children after a Failed Pyeloplasty.” Samowitz, HR and Hanna MK.
Section on Urology of the American Academy of Pediatrics Annual Meeting. New Orleans, Louisiana; October 1991.
“Sperm Retrieval from Testes Biopsy with Fertilization and Pregnancy following ICSI.” Barnes, FL, Samowitz, HR, et al.
Pacific Coast Fertility Society Annual Meeting. Indian Wells, California; April 1996.
“Percutaneous Extraction of Testicular Sperm (PETS): A New Methodology.” Samowitz. HR.
American Urological Association Meeting, Western Section. San Diego, California; July 1996.
“Successful Fertilization and Pregnancy using Testicular Sperm for ICSI.” Chan, SL and Samowitz, HR.
American Urological Association Annual Meeting, Western Section. San Diego, California; July 1996.
“Recent Advances in Incontinence and Voiding Dysfunction.” Parkway Hospital Annual Medical Staff Retreat, Keynote Speaker.
Palm Beach, Florida; September 2003.
“Under Treatment of Over Active Bladder.” University of Tennessee College of Medicine, Internal Medicine Grand Rounds. Chattanooga, Tennessee, June 2005.
“Multiple Sclerosis and the Urologist.” National Multiple Sclerosis Society South Florida Chapter Annual Meeting. Fort Lauderdale, Florida, November 2011.
“Urological Implications of Multiple Sclerosis.” MS Views and News Meeting. Doral, Florida, November 2012.
“Bladder Issues and Symptom Management in Multiple Sclerosis.” MS Views and News Meeting, Boca Raton, Florida, December 2013